Deerfield Private Design International Ii, L.p. - Net Worth and Insider Trading

Deerfield Private Design International Ii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deerfield Private Design International Ii, L.p. owns 5 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Alimera Sciences Inc (ALIM) , and Alpine Immune Sciences Inc (ALPN) among others .

Click here to see the complete history of Deerfield Private Design International Ii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Deerfield Private Design International Ii, L.p.

Ticker Comapny Transaction Date Type of Owner
AVDL Avadel Pharmaceuticals PLC 2018-04-30 other: *Possible member of 10% group
ALIM Alimera Sciences Inc 2015-10-07 10 percent owner & other: Possible Member of 10% Group
ALPN Alpine Immune Sciences Inc 2015-06-23 10 percent owner & other: Possible Member of 10% Group
LIMIT LIMIT 2014-11-21 10 percent owner & other: Possible Member of 10% Group
LIMIT LIMIT 2014-04-22 10 percent owner & other: Possible Members of 10% Group

Deerfield Private Design International Ii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deerfield Private Design International Ii, L.p. Ownership Network

Ownership Network List of Deerfield Private Design International Ii, L.p.

No Data

Ownership Network Relation of Deerfield Private Design International Ii, L.p.

Insider Network Chart

Deerfield Private Design International Ii, L.p. Owned Company Details

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Deerfield Private Design International Ii, L.p. is the other: *Possible member of 10% group of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Deerfield Private Design International Ii, L.p. made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 43,500 shares were bought by its insiders, resulting in a net sale of 60,475 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

Deerfield Private Design International Ii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Deerfield Private Design International Ii, L.p.. You might contact Deerfield Private Design International Ii, L.p. via mailing address: Bison Court, P.o. Box 3460, Road Town, Tortola D8 00000.

Discussions on Deerfield Private Design International Ii, L.p.

No discussions yet.